- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06872385
Profile of Brazilian Climacteric Women: the Brazilian Menopause Study (Brazmenos)
March 10, 2025 updated by: Luciano de Melo Pompei', Faculdade de Medicina do ABC
Cross-sectional study with 1,500 women between 45 and 65 years old.
Women participate by answering questionnaires prepared to get information about their perceptions and knowledge about menopause, hormone therapy and other treatments for menopause.
Study Overview
Detailed Description
This is a cross-sectional study with 1,500 women between 45 and 65 years old.
The subjects participate by answering online questionnaires prepared to get information about their perceptions and knowledge about menopause, hormone therapy and other treatments for menopause.
The distribution of subjects respect the distribution of Brazilian population according to country regions and according to socioeconomic class, and taking into account the information of last official Brazilian demographic census.
Study Type
Observational
Enrollment (Actual)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
Santo Andre, SP, Brazil, 09060650
- Faculdade de Medicina do ABC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Women aged between 45 and 65 years who accept to answer an online questionnaire in order to known their opinions on menopause and treatments for menopause, specially hormone therapy
Description
Inclusion Criteria:
- Women between 45 and 65 years of age
- Women able to participate in a questionnaire on a digital platform and who have a device allowing this access
Exclusion Criteria:
- Pregnant or lactating women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Subjects
Women who meet the inclusion criteria and answered the questionnaire
|
The subject have to answer an online questionnaire about her perceptions on menopause and opinion on treatments for the condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Answer to the questionnaire
Time Frame: Day 1
|
Subject has to answer the questionnaire with several questions about her heath condition, age at menopause, treatments used for menopause
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Luciano M Pompei, Faculdade de Medicina do ABC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 29, 2019
Primary Completion (Actual)
February 11, 2020
Study Completion (Actual)
February 11, 2020
Study Registration Dates
First Submitted
January 20, 2022
First Submitted That Met QC Criteria
March 10, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 10, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 24440719.0.0000.0082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Western Norway University of Applied SciencesCompleted
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
Aydin Adnan Menderes UniversityUludag UniversityCompletedMenopause | Menopause Related ConditionsTurkey (Türkiye)
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasCompletedMenopause Related ConditionsUnited States
Clinical Trials on Answering a questionnaire
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Ludwig-Maximilians - University of MunichEnrolling by invitationDisaster Medicine | Delivery of Health CareGermany
-
Assistance Publique Hopitaux De MarseilleUnknown
-
RxCelerate LtdRxCelerate LimitedUnknownMonoclonal Gammopathy of Unknown SignificanceUnited Kingdom
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University Hospital, BrestActive, not recruitingOrthopedic Disorder | Prosthesis UserFrance
-
Universitair Ziekenhuis BrusselRecruitingAmyloidosis | PolyneuropathyBelgium
-
Nantes University HospitalCompletedSymptomatic Severe Aortic Valve Stenosis in Older PatientsFrance
-
Boston Children's HospitalNational Human Genome Research Institute (NHGRI)Active, not recruitingGenetic Disease | Genetic PredispositionUnited States
-
Medizinische Hochschule Brandenburg Theodor FontaneCompleted